Innovative Blood-Derived Material for Bone Repair Developed

Researchers at the University of Nottingham have pioneered a new type of material known as a "biocooperative" substance, derived from blood, which has demonstrated effectiveness in repairing bones. This advance could lead to personalized regenerative therapies aimed at treating injuries and diseases. The findings were published in Advanced Materials.

The research team utilized peptide molecules that facilitate key processes in natural tissue healing. These peptides were combined with whole blood from patients to create living materials that enhance tissue regeneration. This approach takes advantage of the body's inherent ability to heal minor injuries, which typically begins with liquid blood forming a solid regenerative hematoma (RH)—a complex microenvironment rich in essential cells and factors necessary for healing.

The new methodology involves self-assembling synthetic peptides with patient blood to produce a material that not only mimics but also improves upon the natural RH's structural and functional properties. This material can be easily manipulated and 3D printed while preserving normal biological functions critical for healing, such as platelet behavior and growth factor generation.

Alvaro Mata, who led the study, emphasized the significance of this approach: “For years, scientists have been looking at synthetic approaches to recreate the natural regenerative environment, which has proven difficult given its inherent complexity. Here, we have taken an approach to try to work with biology instead of recreating it. This ‘biocooperative’ approach opens opportunities to develop regenerative materials by harnessing and enhancing mechanisms of the natural healing process. In other words, our approach aims to use regenerative mechanisms that we have evolved with as fabrication steps to engineer regenerative materials.”